This grant funds research in Kenya to study public health threats, improve disease response, and strengthen local and global preparedness against infectious diseases.
Funder: Centers for Disease Control and Prevention - ERA
Due Dates: May 23, 2026 (Optional letter of intent) | June 22, 2026 (Full application, 11:59 p.m. ET)
Funding Amounts: Up to $6,000,000 per year for 5 years; total program funding estimated at $30,000,000; one award expected.
Summary: Supports research, implementation science, and public health evaluations to inform best practices for infectious disease threats in Kenya and strengthen local research capacity.
Key Information: Applicants must demonstrate presence in Kenya, prior collaboration with KEMRI or MoH, and address all four priority areas.
This cooperative agreement from the CDC supports research, implementation science, and public health evaluations to inform best practices for preventing and responding to infectious disease threats in Kenya. The program aims to generate evidence to guide U.S. and global preparedness, reduce disease burden in Kenya, and prevent the spread of health threats across borders. The recipient will work through the Kenya Medical Research Institute (KEMRI) and focus on four required priority areas: influenza and other respiratory pathogens, vaccine-preventable diseases, drug-resistant infections, and global/emerging health threats (e.g., malaria, HIV, tuberculosis, schistosomiasis). The award also supports strengthening local research capacity, research coordination, and administration.